China Metered Dose Inhaler Market Share, Growth| Industry Analysis and Forecast 2019-2025

China metered dose inhaler market is anticipated to grow at a substantial rate of around 4.0% during the forecast period. High level of air pollution and the significant number of smokers in China is boosting the demand for inhalers in the country. Additionally, the rising geriatric population susceptible to asthma and COPD within the country is also driving the demand for inhalers; thereby, leading to the growth of the metered dose inhaler market in the country. From June 2012 to May 2015, a survey was conducted by the Ministry of Health and Ministry of Science and Technology of China. Around 51,000 citizens participated in the survey with 21,500 men and 29,500 women, according to which, it was estimated that about 100 million adults in 2015 had the problem of COPD in the country. The prevalence is higher in men as compared to women. As per the estimation, there were 68.4 million men and 31.5 million women affected by COPD.

To know more information, please request a free report sample https://www.omrglobal.com/request-sample/china-metered-dose-inhaler-market
China metered dose inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators are analyzed. The preventive inhaler segment led the global metered dose inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

A full report of China metered dose inhaler market is available at: https://www.omrglobal.com/industry-reports/china-metered-dose-inhaler-market
China metered dose inhaler market- Segmentation

By Type

• Preventive Inhaler
• Reliever Inhaler
• Long Acting Bronchodilators Inhaler

By Application

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

By End-User

• Homecare
• Hospitals and Clinics
Company Profiles
• 3M Co.
• Adherium Ltd.
• Aradigm Corp.
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• Gerresheimer AG
• GlaxoSmithKline PLC
• Koninklijke Philips N.V.
• Novartis AG
• ResMed Corp.
• Sunovion Pharmaceuticals
• Teva Pharmaceuticals Industries Ltd.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/china-metered-dose-inhaler-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

This release was published on openPR.